Departments of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Departments of and Neurology, Mayo Clinic, Jacksonville, FL, USA.
Acta Neuropathol. 2018 Dec;136(6):873-885. doi: 10.1007/s00401-018-1908-x. Epub 2018 Sep 15.
Women reportedly make up two-thirds of Alzheimer's disease (AD) dementia sufferers. Many estimates regarding AD, however, are based on clinical series lacking autopsy confirmation. The Florida Autopsied Multi-Ethnic (FLAME) cohort was queried for AD cases with a total of 1625 identified ranging in age from 53 to 102 years at death. Standard neuropathologic procedures were employed and clinical information was retrospectively collected. Clinicopathologic and genetic data (MAPT and APOE) were stratified by sex. Within the neuropathologically diagnosed AD cohort, the overall number of women and men did not differ. Men were younger at onset of cognitive symptoms, had a shorter disease duration, and more often had atypical (non-amnestic) clinical presentations. The frequency of autopsy-confirmed AD among women and men stratified by age at death revealed an inverse U-shaped curve in men and a U-shaped curve in women, with both curves having inflections at approximately 70 years of age. Regional counts of neurofibrillary tangles differed in women and men, especially when examined by age intervals. Women had overall greater severity of neurofibrillary tangle counts compared to men, especially in the hippocampus. Men were more often classified as hippocampal sparing AD, whereas limbic predominant AD was more common in women. Men and women did not differ in frequency of MAPT haplotype or APOE genotype. Atypical clinical presentations, younger age at onset and shorter disease duration were more frequent in men, suggesting that the lower reported frequency of AD in men may be due to more frequent atypical clinical presentations not recognized as AD. Our data suggest that neuropathologically diagnosed AD cases have the same frequency of women and men, but their clinical presentations and ages at onset tend to differ.
据报道,女性占阿尔茨海默病(AD)痴呆患者的三分之二。然而,许多关于 AD 的估计都是基于缺乏尸检证实的临床系列。佛罗里达州尸检多民族(FLAME)队列被询问 AD 病例,共确定了 1625 例,死亡时年龄从 53 岁到 102 岁不等。采用标准神经病理学程序,并回顾性收集临床信息。根据性别对临床病理和遗传数据(MAPT 和 APOE)进行分层。在神经病理学诊断的 AD 队列中,女性和男性的总人数没有差异。男性发病时年龄较小,发病时间较短,更常出现非典型(非遗忘型)临床表现。按死亡时年龄分层的女性和男性中经尸检证实的 AD 频率显示出男性呈倒 U 形曲线,女性呈 U 形曲线,两条曲线在大约 70 岁时出现拐点。女性和男性的神经原纤维缠结的区域计数不同,尤其是按年龄间隔检查时。女性的神经原纤维缠结计数总体比男性更严重,尤其是在海马体中。男性更常被归类为海马体保留 AD,而女性更常见的是边缘优势 AD。男性和女性在 MAPT 单倍型或 APOE 基因型的频率上没有差异。男性更常出现非典型临床表现、发病年龄较小和发病时间较短,这表明男性 AD 的报告频率较低可能是由于更常见的未被识别为 AD 的非典型临床表现。我们的数据表明,神经病理学诊断的 AD 病例中女性和男性的频率相同,但他们的临床表现和发病年龄往往不同。